The Role of Mass Spectrometry in Biomarker Discovery and Measurement

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|7|5|525-539

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.7, Iss.5, 2006-07, pp. : 525-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics

By Simpkins Fiona   Czechowicz Josephine A   Liotta Lance   Kohn Elise C  

Pharmacogenomics, Vol. 6, Iss. 6, 2005-09 ,pp. : 647-653

Future Medicine

Access to resources Recommend Favorite

The Application of Mass Spectrometry to Proteomics and Metabolomics in Biomarker Discovery and Drug Development

By  

Current Molecular Pharmacology, Vol. 5, Iss. 2, 2012-01 ,pp. : 301-316

Bentham Science Publishers

Access to resources Recommend Favorite

Early Discovery Drug Screening Using Mass Spectrometry

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 1, 2002-01 ,pp. : 13-33

Bentham Science Publishers

Access to resources Recommend Favorite

Mass Spectrometry in Drug Discovery: A Current Review

By  

Current Drug Discovery Technologies, Vol. 1, Iss. 4, 2004-12 ,pp. : 295-312

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives on Bioanalytical Mass Spectrometry and Automation in Drug Discovery

By  

Current Drug Metabolism, Vol. 9, Iss. 9, 2008-11 ,pp. : 986-994

Bentham Science Publishers

Access to resources Recommend Favorite